logo

For the Inventor, By the Inventor

Constance, Germany

Nycomed Gmbh


USPTO Granted Patents = 63

% Expired Patents = 71.4



Trademarks = 10

Forward Citations = 393

Loading Chart...
Loading Chart...

92 inventors (with patents filed for the assignee):

goldMedal Ulrich Kautz (13 out of 21 patents)

silverMedal Beate Schmidt (11 out of 29 patents)

bronzeMedal Rango Dietrich (9 out of 30 patents)

4.  Hans-Peter Kley (9 out of 17 patents)

5.  Dieter Flockerzi (9 out of 23 patents)

6.  Rudolf Linder (7 out of 19 patents)

7.  Degenhard Marx (6 out of 15 patents)

8.  Rolf-Peter Hummel (5 out of 12 patents)

9.  Geert Jan Sterk (4 out of 28 patents)

10.  Bernd Müller (4 out of 7 patents)

11.  Bernhard Kohl (4 out of 20 patents)

12.  Atsuhiro Nagano (3 out of 5 patents)

13.  Steffen Weinbrenner (3 out of 8 patents)

14.  Andrea Wohlsen (3 out of 6 patents)

15.  Hartmut Ney (3 out of 12 patents)


Core Competencies:
Ciclesonide
PDE4 Inhibitors
Pharmaceutical Products
Drug Delivery
Respiratory Diseases
Pulmonary Surfactant
NSAID Combinations
Stabilized Formulations
Diabetes Treatment
Active Ingredients
Matrix Compositions
Metered Dose Inhalers

63 patents:

1. 8383611 - Ciclesonide containing aqueous pharmaceutical composition (2013-02-26),
2. 8371292 - Use of ciclesonide for the treatment of respiratory diseases (2013-02-12),
3. 8354535 - Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives (2013-01-15),
4. 8329906 - Guanidinyl-substituted hydroxy-6-phenylphenanthridines (2012-12-11),
5. 8324404 - 3-thia-10-aza-phenanthrene derivatives (2012-12-04),
6. 8324391 - Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors (2012-12-04),
7. 8318944 - Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors (2012-11-27),
8. 8304436 - Pyrazolone derivatives as PDE4 inhibitors (2012-11-06),
9. 8288445 - Stable pharmaceutical products (2012-10-16),
10. 8278300 - Use for PDE5 inhibitors (2012-10-02),
11. 8268240 - Ciclesonide-containing sterile aqueous suspension (2012-09-18),
12. 8258124 - Combination medicament (2012-09-04),
13. 8242146 - Combination of a NSAID and a PDE-4 inhibitor (2012-08-14),
14. 8236750 - Composition comprising a pulmonary surfactant and a TNF-derived peptide (2012-08-07),
15. 8202880 - 3-hydroxy-6-phenylphenanthridines as PDE4 inhibitors (2012-06-19),
Nycomed GmbH, headquartered in Constance, Germany, specializes in the development and manufacturing of pharmaceutical compositions aimed at treating various respiratory diseases. The company focuses on innovative technologies such as ciclesonide and PDE4 inhibitors, enhancing drug delivery systems and formulating stabilized products. With a strong emphasis on pulmonary surfactants and NSAID combinations, Nycomed is dedicated to advancing therapeutic options that improve patient outcomes in respiratory health.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Nycomed Gmbh
63 Patents

#3 in Constance

#889 in Germany

#11,611 in the World

Constance, DE
Constance, Germany

Nycomed Gmbh

Forward Citations = 393

92 inventors:

goldMedal Ulrich Kautz (13 out of 21 patents)

silverMedal Beate Schmidt (11 out of 29 patents)

bronzeMedal Rango Dietrich (9 out of 30 patents)

4.  Hans-Peter Kley (9 out of 17 patents)

5.  Dieter Flockerzi (9 out of 23 patents)

Please report any incorrect information to [email protected]
Loading…